BLIMP balloon
DeviceUsing BLIMP balloon to cross lesion
NCT Number: NCT03947398
The purpose of this study is to investigate the effectivness of the Blimp Scoring balloon compared to current available CTO balloon catheters.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Johan Bennett, Leuven, Brabant, Belgium
For this study two case situations are being considered.
6.1.1 Case Situation A Guidewire crossed the lesion, micro catheter does not cross
Case situation A is the circumstansis where a physician is using a guidewire in combination with a micro catheter. When in such case the guidewire is crossing at a certain moment of the procedure and the micro catheter not a balloon crossing attempt is one of the current common options as next step.
For the study the physician will go through following steps
See also appendix I for a flow chart case situation A.
6.1.2 Case Situation B Small balloon catheter (≤ 1.5 (mm)) needed for procedure- no micro catheter used.
Case situation B is the circumstansis where a physician is in the stage of a procedure where he/ she would normally want to select a small balloon catheter ((≤ 1.5 (mm)) to cross an occluded or subtotlal stenotic segment of the coronary artery. When in such case the balloon catheter is not crossing the selection/ attempt with another balloon is one of the current common options as next step.
For the study the physician will go through following steps
6.1.3 Use of the Blimp during the study
The Blimp should be used conform its Instruction For Use (IFU). Following techniques can be attemted to cross the lesion.
6.1.4 Study population and number of subjects A total 128 patients which are being targeted for percutaneous coronary intervention are selected for this study. Pased on power calculations, 128 patiants are sufficient to demonstrate a statistical significant difference in outcome (P<0.05) with 80% power.
6.1.5 Inclusion/exclusion criteria Patients will be enrolled if they require percutaneous coronary intervention (PCI) procedure and
Patients which under normal conditions would be excluded for a PCI procedure by the hospital will be excluded from the study.
6.1.6 Rational and justification of chosen study design The Blimp is intended for balloon dilatation of a coronary artery subtotal lesion/occlusions.
Due to its
the device has several features which can improve the crossabiltiy and initial dilation of severe occluded vessels. The study has been designed such to investigate in an objective and controlled manner if the Blimp Scoring balloon is providing an improved procedural success rate in these matters.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Using BLIMP balloon to cross lesion
using low profile balloon to cross lesion
Time frame: The primary outcome is a procedural assessment
passing of BLIMP or low profile balloon through lesion. If device passess it will be determined a successful outcome, if it does not pass, an unsuccesful outcome.
Universitaire Ziekenhuizen KU Leuven
Other
A Prospective, Multi-Center Registry, Randomized Trial for Evaluation of Effectiveness of the Blimp Scoring Balloon in Lesions Not Crossable With Conventional Balloon or Microcatheter.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05377866
Chronic Total Occlusion of Coronary Artery, Percutaneous Coronary Intervention
Arendal, Agder, Norway
View Trial DetailsNCT04739657
Arterial Occlusive Diseases, Arteriosclerosis
Beijing, China
View Trial DetailsNCT05605288
Arterial Occlusive Diseases, Arteriosclerosis
Charleroi, Belgium
View Trial DetailsNCT07683143
Percutaneous Coronary Intervention
Kaifeng, Henan, China
View Trial Details